AU4173896A - Use of chelate compounds as diagnostic agents in the x-ray examination of liver and bile ducts - Google Patents

Use of chelate compounds as diagnostic agents in the x-ray examination of liver and bile ducts

Info

Publication number
AU4173896A
AU4173896A AU41738/96A AU4173896A AU4173896A AU 4173896 A AU4173896 A AU 4173896A AU 41738/96 A AU41738/96 A AU 41738/96A AU 4173896 A AU4173896 A AU 4173896A AU 4173896 A AU4173896 A AU 4173896A
Authority
AU
Australia
Prior art keywords
liver
diagnostic agents
chelate compounds
ray examination
bile ducts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU41738/96A
Inventor
Thomas Balzer
Michael Bauer
Werner Krause
Franz-Karl Maier
Andreas Muhler
Wolf-Rudiger Press
Gabriele Schuhmann-Giampieri
Ulrich Speck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of AU4173896A publication Critical patent/AU4173896A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/0002General or multifunctional contrast agents, e.g. chelated agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
AU41738/96A 1994-11-30 1995-11-20 Use of chelate compounds as diagnostic agents in the x-ray examination of liver and bile ducts Abandoned AU4173896A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US480566 1983-03-30
US35108694A 1994-11-30 1994-11-30
US351086 1994-11-30
US38740895A 1995-02-13 1995-02-13
US387408 1995-02-13
US48056695A 1995-06-07 1995-06-07
PCT/EP1995/004547 WO1996016678A1 (en) 1994-11-30 1995-11-20 Use of chelate compounds as diagnostic agents in the x-ray examination of liver and bile ducts

Publications (1)

Publication Number Publication Date
AU4173896A true AU4173896A (en) 1996-06-19

Family

ID=27407981

Family Applications (1)

Application Number Title Priority Date Filing Date
AU41738/96A Abandoned AU4173896A (en) 1994-11-30 1995-11-20 Use of chelate compounds as diagnostic agents in the x-ray examination of liver and bile ducts

Country Status (13)

Country Link
EP (1) EP0794800A1 (en)
JP (1) JPH10509734A (en)
CN (1) CN1167443A (en)
AU (1) AU4173896A (en)
CA (1) CA2206558A1 (en)
CZ (1) CZ166797A3 (en)
FI (1) FI972285A (en)
HU (1) HUT77553A (en)
IL (1) IL116207A0 (en)
NO (1) NO972458L (en)
PL (1) PL320482A1 (en)
SK (1) SK68897A3 (en)
WO (1) WO1996016678A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6117412A (en) * 1995-01-26 2000-09-12 Nycomed Imaging As Non-cluster type bismuth compounds
GB9501560D0 (en) * 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents
EP0885616A1 (en) * 1997-06-20 1998-12-23 Schering Aktiengesellschaft Use of intravenous contrast agents, and apparatus for projectionsmammography
SG186259A1 (en) * 2010-06-11 2013-01-30 Bayer Ip Gmbh Process for preparing crystalline 3,6,9-triaza-3,6,9-tris(carboxymethyl)-4-(4-ethoxybenzyl)undecanedioic acid and use for production of primovist®
JP2012254973A (en) * 2011-05-18 2012-12-27 Sumitomo Chemical Co Ltd Aliphatic amine-coordinated cerium complex and device containing the complex
EP3107580B1 (en) * 2014-02-18 2024-02-14 Medesis Pharma Use of a reverse-micellar system for delivering chelators of radionuclides and metals

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3922005A1 (en) * 1989-06-30 1991-01-10 Schering Ag DERIVATIVED DTPA COMPLEXES, PHARMACEUTICAL AGENTS CONTAINING THESE COMPOUNDS, THEIR USE AND METHOD FOR THE PRODUCTION THEREOF
DE4011684A1 (en) * 1990-04-06 1991-10-10 Schering Ag DTPA MONOAMIDES, PHARMACEUTICAL AGENTS CONTAINING THESE COMPOUNDS, THEIR USE AND METHOD FOR THE PRODUCTION THEREOF
GB9122984D0 (en) * 1991-10-30 1991-12-18 Salutar Inc Contrast media

Also Published As

Publication number Publication date
EP0794800A1 (en) 1997-09-17
NO972458D0 (en) 1997-05-29
NO972458L (en) 1997-05-29
HUT77553A (en) 1998-05-28
WO1996016678A1 (en) 1996-06-06
CA2206558A1 (en) 1996-06-06
FI972285A0 (en) 1997-05-29
JPH10509734A (en) 1998-09-22
SK68897A3 (en) 1998-10-07
CZ166797A3 (en) 1997-11-12
PL320482A1 (en) 1997-09-29
MX9703974A (en) 1997-09-30
FI972285A (en) 1997-05-29
CN1167443A (en) 1997-12-10
IL116207A0 (en) 1996-01-31

Similar Documents

Publication Publication Date Title
AU4158596A (en) Calixarene conjugates useful as mri and ct diagnostic imaging agents
PL320462A1 (en) Application of metal complexes as diagnostic agents for x-raying liver and bile ducts in computer tomography
AU2124397A (en) Compositions and methods for the treatment and diagnosis of cardiovascular disease
AU2276495A (en) Contrast agents for diagnostic imaging
HUP9902068A3 (en) Methods and compositions for the diagnosis and treatment of cancer
AU5355094A (en) Therapeutic and diagnostic imaging compositions and methods
AU1136297A (en) Methods and compositions for diagnosis of hyperhomocysteinemia
AU3816697A (en) Conservin compositions and therapeutic and diagnostic uses therefor
AU1575697A (en) Compositions and methods for the treatment and diagnosis of cancer
BR9508110A (en) Triterpene derivative and medical composition
AU2821295A (en) Compositions and methods for the treatment of tumors
AU4173896A (en) Use of chelate compounds as diagnostic agents in the x-ray examination of liver and bile ducts
AU4608296A (en) Methods and compositions for treatment of solid tumors in vivo
AU3436295A (en) Diagnostic imaging agent
AU2554595A (en) Compositions and uses thereof in the diagnosis of psoriasis
AU6786898A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU6786598A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
IL137836A0 (en) Methods and compositions for diagnosis of hepatoma
AU3164395A (en) Use of chelates as x-ray contrast mediums
AU6786798A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU8580598A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU6786698A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
ZA9510200B (en) Use of metal complexes as x-ray diagnostic agents for the liver and gallbladder
AU5093993A (en) Nonionic X-ray contrast agents compositions and methods
AU692590C (en) Diagnostic imaging agent